Annexon, Inc. (ANNX) vs Immix Biopharma, Inc. (IMMX)
- Annexon, Inc. ANNX 3.41 −5.28%
- Immix Biopharma, Inc. IMMX 7.98 −8.06%
Annexon, Inc. and Immix Biopharma, Inc. are both Biotechnology companies. Annexon, Inc. and Immix Biopharma, Inc. are of similar size ($719.6M and $682.5M). Across the 8 metrics below, Immix Biopharma, Inc. leads on 7 and Annexon, Inc. on 1.
Valuation
Profitability
| Metric | ANNX | IMMX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (105.26%) | (34.18%) | (56.36%) |
| Return on assets | (79.38%) | (31.34%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack